-
A rapid point-of-care diagnostic designed for use with the Sofia and Sofia 2 fluorescent immunoassay (FIA) analyzers
Uses
- COVID-19 Diagnosis:
- Detects the SARS-CoV-2 nucleocapsid protein antigen in nasal or nasopharyngeal swabs from symptomatic patients
- Screening:
- Approved for the serial testing of asymptomatic individuals
- Point-of-Care Testing:
- Utilized in hospital laboratories, urgent care clinics, and other healthcare settings operating under a CLIA Certificate of Waiver
Features
- Rapid Results:
- Delivers objective, automated results in just 15 minutes
- Fluorescent Technology:
- Uses advanced immunofluorescence to eliminate the subjectivity of visual, manual test reads
- Flexible Work Modes:
- Offers "Walk Away" mode (multitasking) and "Read Now" mode (throughput and batching) to handle varying testing volumes
- Data Management:
- Integrates seamlessly with the Virena system for automated tracking, government reporting, and disease mapping
- CLIA Waived:
- Simple to perform with a low risk of erroneous results
Benefits
- Workflow Efficiency:
- Helps clinicians make rapid triage and isolation decisions
- Reliability:
- Delivers highly accurate results with no cross-reactivity to seasonal coronaviruses
- All-Inclusive Kit:
- Contains all necessary components—including test cassettes, reagent tubes, swabs, and positive/negative controls—ready for immediate testing
- Convenient Storage:
- Can be stored at room temperature
